DK1257642T3 - Partnere til PTB1-domænet af FE65, fremstilling og anvendelser - Google Patents
Partnere til PTB1-domænet af FE65, fremstilling og anvendelserInfo
- Publication number
- DK1257642T3 DK1257642T3 DK01907727T DK01907727T DK1257642T3 DK 1257642 T3 DK1257642 T3 DK 1257642T3 DK 01907727 T DK01907727 T DK 01907727T DK 01907727 T DK01907727 T DK 01907727T DK 1257642 T3 DK1257642 T3 DK 1257642T3
- Authority
- DK
- Denmark
- Prior art keywords
- partners
- applications
- manufacturing
- ptb1 domain
- present
- Prior art date
Links
- 102100036439 Amyloid beta precursor protein binding family B member 1 Human genes 0.000 title abstract 4
- 101100243745 Schizosaccharomyces pombe (strain 972 / ATCC 24843) ptb1 gene Proteins 0.000 title 1
- 238000004519 manufacturing process Methods 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 2
- 230000000694 effects Effects 0.000 abstract 1
- 230000012202 endocytosis Effects 0.000 abstract 1
- 230000003993 interaction Effects 0.000 abstract 1
- 230000010189 intracellular transport Effects 0.000 abstract 1
- 230000000144 pharmacologic effect Effects 0.000 abstract 1
- 230000001105 regulatory effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Neurosurgery (AREA)
- Genetics & Genomics (AREA)
- Neurology (AREA)
- Toxicology (AREA)
- Biophysics (AREA)
- Biomedical Technology (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Gastroenterology & Hepatology (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- General Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Thin Magnetic Films (AREA)
- Inorganic Compounds Of Heavy Metals (AREA)
- Crystals, And After-Treatments Of Crystals (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Soft Magnetic Materials (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR0001628A FR2804962B1 (fr) | 2000-02-10 | 2000-02-10 | Partenaires du domaine ptb1 de fe65, preparation et utilisations |
| US19850000P | 2000-04-18 | 2000-04-18 | |
| PCT/FR2001/000361 WO2001059104A1 (fr) | 2000-02-10 | 2001-02-07 | Partenaires du domaine ptb1 de fe65, preparation et utilisations |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK1257642T3 true DK1257642T3 (da) | 2009-03-30 |
Family
ID=26212162
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK01907727T DK1257642T3 (da) | 2000-02-10 | 2001-02-07 | Partnere til PTB1-domænet af FE65, fremstilling og anvendelser |
Country Status (17)
| Country | Link |
|---|---|
| US (2) | US6696273B2 (es) |
| EP (1) | EP1257642B1 (es) |
| KR (1) | KR100802687B1 (es) |
| AT (1) | ATE415476T1 (es) |
| AU (2) | AU2001235625B2 (es) |
| BR (1) | BR0108247A (es) |
| CA (1) | CA2399939A1 (es) |
| CY (1) | CY1108758T1 (es) |
| DE (1) | DE60136688D1 (es) |
| DK (1) | DK1257642T3 (es) |
| ES (1) | ES2315273T3 (es) |
| IL (1) | IL151147A0 (es) |
| MX (1) | MXPA02007620A (es) |
| NO (1) | NO330798B1 (es) |
| NZ (1) | NZ520697A (es) |
| PT (1) | PT1257642E (es) |
| WO (1) | WO2001059104A1 (es) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE10146737A1 (de) * | 2001-09-22 | 2003-04-10 | Aventis Pharma Gmbh | Coniosulfide und deren Derivate, Verfahren zu ihrer Herstellung und Verwendung als Arzneimittel |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5389526A (en) * | 1989-11-02 | 1995-02-14 | Slade; Martin B. | Plasmid vectors for cellular slime moulds of the genus dictyostelium |
| US5928882A (en) * | 1997-10-24 | 1999-07-27 | The Rockefeller University | Treatment and prevention of neurodegenerative diseases using modulators of Fe65 |
| EP1040118A4 (en) * | 1997-11-26 | 2003-04-09 | Inst Genetics Llc | Protein secretion and the corresponding polynucleotides encoding it |
| US6214582B1 (en) * | 1998-11-16 | 2001-04-10 | The Research Foundation Of State University Of Ny | Y2H35 a strong IKK binding protein |
-
2001
- 2001-02-07 DK DK01907727T patent/DK1257642T3/da active
- 2001-02-07 AT AT01907727T patent/ATE415476T1/de active
- 2001-02-07 AU AU2001235625A patent/AU2001235625B2/en not_active Ceased
- 2001-02-07 KR KR1020027010351A patent/KR100802687B1/ko not_active IP Right Cessation
- 2001-02-07 EP EP01907727A patent/EP1257642B1/fr not_active Expired - Lifetime
- 2001-02-07 WO PCT/FR2001/000361 patent/WO2001059104A1/fr active IP Right Grant
- 2001-02-07 MX MXPA02007620A patent/MXPA02007620A/es active IP Right Grant
- 2001-02-07 ES ES01907727T patent/ES2315273T3/es not_active Expired - Lifetime
- 2001-02-07 PT PT01907727T patent/PT1257642E/pt unknown
- 2001-02-07 BR BR0108247-7A patent/BR0108247A/pt not_active IP Right Cessation
- 2001-02-07 NZ NZ520697A patent/NZ520697A/en not_active IP Right Cessation
- 2001-02-07 AU AU3562501A patent/AU3562501A/xx active Pending
- 2001-02-07 IL IL15114701A patent/IL151147A0/xx unknown
- 2001-02-07 DE DE60136688T patent/DE60136688D1/de not_active Expired - Lifetime
- 2001-02-07 CA CA002399939A patent/CA2399939A1/fr not_active Abandoned
- 2001-02-09 US US09/780,996 patent/US6696273B2/en not_active Expired - Fee Related
-
2002
- 2002-08-09 NO NO20023783A patent/NO330798B1/no not_active IP Right Cessation
-
2003
- 2003-12-03 US US10/726,721 patent/US6942982B2/en not_active Expired - Fee Related
-
2009
- 2009-02-05 CY CY20091100140T patent/CY1108758T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| WO2001059104A1 (fr) | 2001-08-16 |
| AU3562501A (en) | 2001-08-20 |
| EP1257642A1 (fr) | 2002-11-20 |
| US20020061553A1 (en) | 2002-05-23 |
| IL151147A0 (en) | 2003-04-10 |
| US6696273B2 (en) | 2004-02-24 |
| CY1108758T1 (el) | 2014-04-09 |
| NO20023783L (no) | 2002-09-09 |
| ATE415476T1 (de) | 2008-12-15 |
| US20040166109A1 (en) | 2004-08-26 |
| ES2315273T3 (es) | 2009-04-01 |
| CA2399939A1 (fr) | 2001-08-16 |
| MXPA02007620A (es) | 2002-12-13 |
| PT1257642E (pt) | 2009-01-30 |
| US6942982B2 (en) | 2005-09-13 |
| KR20020079844A (ko) | 2002-10-19 |
| KR100802687B1 (ko) | 2008-02-12 |
| NO330798B1 (no) | 2011-07-18 |
| NO20023783D0 (no) | 2002-08-09 |
| EP1257642B1 (fr) | 2008-11-26 |
| DE60136688D1 (de) | 2009-01-08 |
| AU2001235625B2 (en) | 2007-01-11 |
| NZ520697A (en) | 2005-11-25 |
| BR0108247A (pt) | 2002-11-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RS50660B (sr) | Dihidrotetrabenazini i farmaceutske kompozicije koje ih sadrže | |
| BR0112969A (pt) | Método de utilização de dicetopiperazinas e composições contendo-as | |
| SV2003001144A (es) | FORMAS CRISTALINAS DE LA SAL DE CALCIO DEL ACIDO [R-(R*,R*)]-2-(4-FLUOROFENIL)-ß,ô-DIHIDROXI-5-(1-METILETIL)-3-FENIL-4[(FENILAMINO)CARBONIL]-1H-PIRROL-1-HEPTANOICO (2:1) REF. PC430-01FJT | |
| ECSP045245A (es) | N-aril-2-oxazolidinona-5-carboxamidas y sus derivados | |
| DOP2001000297A (es) | Nuevas imidazotriazinonas sustituidas | |
| EA200800201A1 (ru) | Кристаллические формы 4-метил-n-[3-(4-метилимидазол-1-ил)-5-трифторметилфенил]-3-(4-пиридин-3-илпиримидин-2-иламино)бензамида | |
| EA200702529A1 (ru) | Фунгицидная комбинация биологически активных веществ | |
| EA201270630A1 (ru) | Гетероциклические сетр ингибиторы | |
| EA200800698A1 (ru) | Способ стабилизации фармацевтических форм для введения, включающих микроорганизмы | |
| ATE468341T1 (de) | Thienopyrazole | |
| TW200605786A (en) | Dermally applicable liquid formulations for controlling parasitic arthropods on animals | |
| NO20083050L (no) | Forbindelser og fremgangsmater for hemming av interaksjon av Bcl-proteiner med bindingspartnere | |
| EA200601743A1 (ru) | Выделенный полипептид реналазы и его применение | |
| ATE452646T1 (de) | Zusammensetzungen mit epigallocatechingallat und proteinhydrolysat | |
| DE50111331D1 (de) | Neue verwendung von proteinhydrolysaten | |
| ATE457977T1 (de) | Biguanidderivate | |
| EA200801453A1 (ru) | Комбинация биологически активных веществ фунгицидного действия | |
| DE602005026565D1 (de) | 5-(2,2-dimethyl-cyclopropyl)-3-methylpent-2-ennitril als geruchs- und geschmacksstoff | |
| CU23309B7 (es) | Compuestos anã logos de astrobilurinas y su uso como acaricida e insecticida | |
| ATE527280T1 (de) | Fluoreszentprotein und chromoprotein | |
| DK1257642T3 (da) | Partnere til PTB1-domænet af FE65, fremstilling og anvendelser | |
| TR199901017A2 (xx) | B�cek ilac� terkibi. | |
| SE0102910D0 (sv) | New use | |
| EA200400751A1 (ru) | Применение дезоксипеганина для лечения клинической депрессии | |
| DE59808166D1 (de) | Verwendung von 2-methyl-thiazolidin-2,4-dicarbonsäure als mukolytikum |